Related Experiment Video
Updated: Jul 12, 2026
11:29
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
[Beta-adrenergic receptor blocker poisoning]
1Clinic of Intensive Care, Kaunas University of Medicine, Eiveniu 2, Kaunas, Lithuania. minjan@sonex.lt
Medicina (Kaunas, Lithuania)
|September 5, 2007
Summary
Beta-blocker overdose is rare but serious. This review details toxicity, clinical presentation, and treatment for beta-adrenergic receptor antagonist overdoses.
Area of Science:
- Pharmacology
- Toxicology
- Cardiology
Background:
- Beta-adrenergic receptor blockers are widely used for various cardiovascular and non-cardiovascular conditions.
- These drugs act as competitive antagonists at beta(1) and/or beta(2) adrenergic receptors.
- Overdoses, though uncommon, pose significant risks of morbidity and mortality.
Purpose of the Study:
- To review the properties of beta-adrenergic receptor blockers.
- To outline toxic and referral doses for beta-blocker overdoses.
- To analyze the clinical presentation, diagnosis, and management of beta-blocker overdose.
Main Methods:
- Literature review of beta-adrenergic receptor blocker properties and overdose management.
- Analysis of clinical manifestations, diagnostic approaches, and treatment strategies.
- Evaluation of clinical course and prognosis in beta-blocker overdose cases.
Main Results:
- Beta-blocker overdoses present with cardiovascular, neurologic, and pulmonary complications.
- Treatment strategies include gastrointestinal decontamination, pharmacologic interventions (atropine, glucagon, insulin), and supportive care.
- Extracorporeal procedures and cardiac pacing may be indicated in severe cases.
Conclusions:
- Understanding beta-blocker properties is crucial for managing overdose.
- Prompt diagnosis and appropriate treatment are essential for improving outcomes.
- This review provides guidance on toxic doses, clinical presentation, and management of beta-blocker overdose.
Related Concept Videos
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:00Drug Toxicity: Overview
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...